LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ) just unveiled an update.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has reported a significant increase in its financial performance for the year ended December 31, 2024. The company achieved a 44.4% rise in revenue and a 62.2% increase in net profit attributable to shareholders, while also reducing research and development expenses by 6.6%. The Board has recommended a higher final dividend of RMB0.62 per share. Additionally, the company has transitioned its financial reporting standards to the China Accounting Standards for Business Enterprises (CASBE) to improve efficiency and reduce costs.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the medical technology industry. The company focuses on the development and distribution of medical devices and technology solutions.
YTD Price Performance: -3.21%
Average Trading Volume: 286,615
Technical Sentiment Signal: Buy
For detailed information about 2291 stock, go to TipRanks’ Stock Analysis page.